Schering-Plough CEO on Vytorin

Previous Video: CNBC.com News Now
Next Video: RBA Expected to Hold Rates

Airtime: ET

Shares of Schering-Plough plummeted today after a cardiology conference advised patients not to use SGP's most important drug - Vytorin. Fred Hassan, CEO of Schering-Plough, discusses this situation with Mad Money's Jim Cramer.

Previous Video: CNBC.com News Now
Next Video: RBA Expected to Hold Rates

LATEST VIDEO

- The Week That Was
  A roundup of the week's business and financial news, with CNBC's Michelle Caruso-Cabrera.
- The Week Ahead
  A look ahead to the stories likely to make headlines next week, with CNBC's Michelle Caruso-Cabrera.

LATEST MAD MONEY VIDEOS

- Mad Money Recap
  Cramer recaps the anatomy of a bull market.
- Kill Bull Warnings
  Factors that might kill a bull market.
- Extreme Measures?
  Cramer says that stocks tend to move in repetitive markets.
More Video

Data is a real-time snapshot *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc. All Rights Reserved.
A Division of NBC Universal

Schering-Plough CEO on Vytorin

More Videos from CNBC

TOP VIDEO

LATEST VIDEO

LATEST MAD MONEY VIDEOS